The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridioides difficile infection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines.

Autor: Mullish BH; Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, UK.; Departments of Gastroenterology and Hepatology, St Mary's Hospital, Imperial College Healthcare NHS Trust, London, UK., Merrick B; Centre for Clinical Infection and Diagnostics Research, Guy's and St Thomas' NHS Foundation Trust, King's College London, London, UK., Quraishi MN; Department of Gastroenterology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.; Microbiome Treatment Centre, University of Birmingham, Edgbaston, UK.; Institute of Cancer and Genomic Sciences, University of Birmingham, London, UK., Bak A; Healthcare Infection Society, London, UK., Green CA; Department of Infectious Diseases & Tropical Medicine, University Hospitals NHS Foundation Trust, Birmingham Heartlands Hospital, Birmingham, UK.; School of Chemical Engineering, University of Birmingham, Birmingham, UK., Moore DJ; Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK., Porter RJ; Department of Microbiology, Royal Devon and Exeter Hospitals, Barrack Road, UK., Elumogo NT; Quadram Institute Bioscience, Norwich Research Park, Norwich, UK.; Norfolk and Norwich University Hospital, Norwich, UK., Segal JP; Department of Gastroenterology, Royal Melbourne Hospital, Melbourne, Victoria, Australia.; Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia., Sharma N; Department of Gastroenterology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.; Microbiome Treatment Centre, University of Birmingham, Edgbaston, UK.; Institute of Cancer and Genomic Sciences, University of Birmingham, London, UK., Marsh B; Lay representative for FMT Working Party, Healthcare Infection Society, London, UK., Kontkowski G; Lay representative for FMT Working Party, Healthcare Infection Society, London, UK.; C.diff support, London, UK., Manzoor SE; Microbiome Treatment Centre, University of Birmingham, Edgbaston, UK., Hart AL; Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, UK.; Department of Gastroenterology and Inflammatory Bowel Disease Unit, St Mark's Hospital and Academic Institute, Middlesex, UK., Settle C; South Tyneside and Sunderland NHS Foundation Trust, South Shields, UK., Keller JJ; Department of Gastroenterology, Haaglanden Medisch Centrum, The Hague, The Netherlands.; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands., Hawkey P; Microbiome Treatment Centre, University of Birmingham, Edgbaston, UK.; Public Health Laboratory, Faculty of Medicine, University of Birmingham, Birmingham, UK., Iqbal TH; Department of Gastroenterology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.; Microbiome Treatment Centre, University of Birmingham, Edgbaston, UK.; Institute of Cancer and Genomic Sciences, University of Birmingham, London, UK., Goldenberg SD; Centre for Clinical Infection and Diagnostics Research, Guy's and St Thomas' NHS Foundation Trust, King's College London, London, UK h.williams@imperial.ac.uk Simon.Goldenberg@gstt.nhs.uk., Williams HRT; Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, UK h.williams@imperial.ac.uk Simon.Goldenberg@gstt.nhs.uk.; Departments of Gastroenterology and Hepatology, St Mary's Hospital, Imperial College Healthcare NHS Trust, London, UK.

Publikováno v: Gut [Gut] 2024 Jun 06; Vol. 73 (7), pp. 1052-1075. Date of Electronic Publication: 2024 Jun 06.